Myelodysplastic Neoplasms and Acute Myeloid Leukemia
Research activity includes myelodysplastic syndrome and acute myeloid leukemia, particularly in patients with disease that is refractory to hypomethylating agent-based treatment. The sponsor also supports studies in higher-risk chronic myelomonocytic leukemia and lower-risk MDS with clinically significant anemia.
- Imetelstat
- Azacitidine
- Venetoclax
- Tagraxofusp
- Erythroid response
These studies focus on hematologic disease control, marrow failure, and response patterns in patients with limited treatment options.
Anemia in Myelodysplastic Syndromes
The sponsor is involved in trials addressing anemia associated with very low-, low-, and intermediate-risk myelodysplastic neoplasms. The clinical interest centers on improvement of red blood cell production and measurable hematologic benefit in patients with chronic bone marrow disorders.
- Lower-risk MDS
- Hemoglobin improvement
- Hematologic response
- Marrow failure syndromes
Work in this area reflects a focus on symptomatic burden and blood count recovery in myeloid malignancies.
Cardiac Surgery and Postoperative Atrial Fibrillation
Clinical research also covers patients undergoing open-heart surgery, with attention to inflammatory responses and rhythm complications after surgery. The sponsor’s portfolio includes studies in cardiovascular disease that examine recovery-related outcomes following surgical intervention.
- Vitamin C
- Fish oil
- Atrial fibrillation
- Atrial flutter
- Atrial tachycardia
These trials address perioperative inflammation and cardiac rhythm disturbance in the surgical setting.
Critical Care and Perioperative Medicine
Additional research interests extend to intensive care unit populations and patients with critical illness undergoing surgery. This includes clinical questions related to postoperative recovery, systemic stress, and complication prevention in high-acuity settings.
- Intensive care unit
- Critical illness
- Surgical recovery
- Systemic inflammation
The sponsor’s trial activity in this area connects surgical care with intensive care medicine and perioperative risk management.
